Status:
COMPLETED
The Outcomes of Laparoscopic Hybrid Surgery Versus Totally Open Surgery
Lead Sponsor:
Changhai Hospital
Conditions:
Resectable Simultaneous Colorectal Cancer Liver Metastasis
Eligibility:
All Genders
Brief Summary
Simultaneous colorectal cancer liver metastasis (SCRLM) is one of the risk factors for poor prognosis in colorectal cancer. Surgical resection of primary and metastatic lesions is the first choice of ...
Eligibility Criteria
Inclusion
- Liver metastasis was detected while the colorectal cancer was diagnosed.
- Both the primary lesions and liver metastases were confirmed by postoperative pathological examination.
- Clinical data is complete.
Exclusion
- Patients with unresectable extrahepatic metastases.
- Patients with other malignant tumor diseases that have not been cured.
- Clinical and pathological data were missed or incomplete follow-up data.
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2024
Estimated Enrollment :
266 Patients enrolled
Trial Details
Trial ID
NCT06550700
Start Date
January 1 2010
End Date
August 1 2024
Last Update
April 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Colorectal Surgery in Changhai Hospital
Shanghai, Shanghai Municipality, China, 200433